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Abstract

Rosai-Dorfman disease (RDD) is a benign, self-limiting histiocytosis of unknown etiology. The classic
form of the condition includes a painless cervical lymphaenopathy accompanied by fever, weight loss
and an elevated ESR. Extra nodal RDD (ENRDD) is most frequent in the head and neck. Thirty-eight
cases of ENRDD have been described. Seven cases of ENRDD were identified in our pathology biopsy
services. The demographic and clinical information was tabulated logically on the basis of age, gender,
location and presence or absence of symptoms, treatment and follow-up. Radiographic and
histopathological features were also examined. The findings in these cases were correlated with those
available from the previously reported cases. Six cases affected women and one case was diagnosed in
a male. The age ranged from 22–55 years. Three cases presented as a nasal mass. One of these lesions
extended into the paranasal sinuses. One case was located in the maxilla and extended to involve the
maxillary sinus. Three cases were diagnosed in the mandible. The maxillary and one mandibular lesion
(Case 2) resulted in significant painful irregular bone destruction with a non-healing socket and tooth
mobility respectively. One mandibular lesion was asymptomatic (Case 6). The third case affecting the
mandible presented as a rapidly expansile mass following a tooth extraction (Case 7). Nasal masses
presented with symptoms of obstruction. Nasal masses were excised with no recurrence from up to 2–
3 years of follow-up. The mandibular lesions were curetted aggressively. The oral mass in Case 7 was
excised synchronously. No recurrence up to 2 years was recorded in Case 2. Follow-up information is
not available for Cases 6 and 7. The maxillary lesion was not intervened surgically. The patient has
persistent but stable disease for a follow-up period of 2 years. ENRDD is rarely considered in the
differential diagnosis in the absence of lymph node involvement. Lesions of ENRDD resemble many
other histiocytic and histiocyte-rich lesions of the head and neck. This makes the diagnosis of ENRDD
challenging with the potential for under diagnosis or misdiagnosis and delay in treatment.
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Introduction

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy
(SHML), was described first by Juan Rosai and Ronald F. Dorfman in 1969 as a benign, self-limiting
histiocytosis of unknown etiology [1]. The classic clinical presentation is that of a painless cervical
lymphadenopathy accompanied by fever, elevated erythrocyte sedimentation rate, weight loss,
rhinorrhea and occasionally hepatosplenomegaly [1, 2]. Approximately 43% of RDD patients present

without nodal involvement [3]. Extra nodal RDD (ENRDD) has been most frequently reported in the
eyes, skin, nasal cavity and bones [4]. Among the extra nodal sites, the head and neck region is most
commonly affected [5]. Most of the extra nodal cases of RDD in the head and neck region affect the
nasal cavity, pharynx and paranasal sinuses. RDD of the paranasal sinuses and the oral cavity including
the bones of the maxilla and the mandible without lymph node involvement is exceedingly rare [6]. A
search of English language literature produced 38 cases of RDD of the gnathic bones, nose and
paranasal sinuses without nodal involvement. We present seven additional cases of RDD of the nose,
paranasal sinuses and the jawbones in the absence of nodal disease. The clinical, histopathological and
immunohistochemical features of ENRDD are discussed and pertinent literature is reviewed.

Materials and Methods

Seven cases of RDD of the jawbones, nose and paranasal sinuses were retrieved from the pathology
services at Oral Pathology Consultants (Grosse Pointe Woods, MI), the University of Washington
(Seattle, WA), Emory University (Atlanta, GA), Brigham & Women’s Hospital (Boston, MA), Joint
Pathology Center (Silver Spring, MD) and Navy Medical Center (Portsmouth, VA). A sequential record
of clinical features including demographic data, symptoms, physical signs, radiographic findings,
treatment and follow-up of the patients when available was recorded (Table 1). A search of the
English-language literature was performed using search terms Rosai-Dorfman, Sinus histiocytosis with
massive lymphadenopathy, extranodal Rosai-Dorfman, with location combinations such as “Mandible”,
“Maxilla”, “Gnathic”, “Oral”, “Nasal cavity”, “Sinus”, “Sinonasal” and “Nose”. Reports where the
patient had a history of nodal disease were excluded. A total of 38 such cases were documented
(Table 2).

Table 1 Salient demographic, clinical and radiographic features of cases of ENRDD of the head and neck in the present series
Case Sex Age Location

Clinical
features
Pain, nonhealing
extraction
socket
Pain, mobility
of tooth #19

Imaging study findings

Treatment

Outcome

Right maxilla and sinus destruction up
to pterygoid plates

Observation

Persistent
disease

Aggressive
Curettage

No
recurrence

2 years

Excision

No
recurrence

2 years

Excision

No
recurrence
No
recurrence
Not
available

3 years

Not
available

Not
available

1

F

46

Maxilla,
maxillary
sinus

2

F

26

Mandible

3

F

54

Chronic
sinusitis

4

F

55

Nasal cavity
and
paranasal
sinuses
Nasal cavity

Obstruction

Multiple irregular osteolytic foci.
Scooped out appearance of superior
alveolus. Tooth #19 appears extruded
3.0 × 1.5 × 3.0 cm mass, right anterior
nose involving anterior and mid
portions of inferior and middle
turbinate
Not available

5

F

22

Nasal cavity

Obstruction

Not available

Excision

6

M

26

Mandible

Incidental
finding

Aggressive
curettage

7

F

38

Mandible

Rapidly
growing
expansile
mass

Vaguely outlined radiolucency
extending from mesial aspect of first
molar tooth to mid ramus. Cortical
thinning but no significant expansion.
2.5 cm × 2.3 cm × 1.3 cm mass creating
a radiolucency with well-defined
borders. Buccal and lingual cortical
compromise

Age range: 22–55 years (mean: 38.14 years); Gender distribution: Male: 1, Female: 6
Table 2 Salient features of 38 previously reported cases of ENRDD
Author/s
Number Sex Age Location
Presentation
of cases

Excision of mass
followed by
aggressive
curettage of intra
bony component.

Treatment

Outcome

FollowUp
2 years

3 years
Not
available

Follow-Up

Shemen et al.
[25]
Wenig et al.
[26]

1

F

42

6

F

42

F

46

F

47
54
64
69
57

Gregor et al.
[27]
Remadi et al.
[28]

1

F
F
M
M

1

M

12

Ku et al. [29]

1

M

40

Kademani et
al. [30]
Dodson et al.
[31]

1

F

44

1

F

56

Sennes et al.
[32]

2

M

18

M

38

Gupta et al.
[33]

1

M

6

Nasal cavity,
sinus, septum
Maxillary sinus

Nasal mass,
obstruction
Nasal obstruction

Excision, radiation

Maxillary &
ethmoid
sinuses
3rd molar site
soft tissue and
bone
Nasal cavity
Nasal septum
Nasal cavity
Nasal cavity,
ethmoid sinus
Nasal cavity,
maxillary &
frontal sinus
Nasal cavity,
septum
Maxilla, nasal
cavity
Nasal cavity,
nasopharynx

Bilateral proptosis,
sinusitis, saddle nose

Nasal cavity,
septum
Nasal cavity,
maxillary sinus
Nasal cavity

1 year

Excision

Multiple
recurrences
Multiple
recurrences
Progression

Tenderness

Excision

No recurrence

N/A

Epistaxis
Nasal obstruction
Nasal obstruction
Nasal obstruction

Excision
Excision
Excision
Excision

No recurrence
No recurrence
recurrence
No recurrence

N/A
N/A
3 years
7 years

Epistaxis,
enophthalmos

Excision, steroids

Multiple
recurrences

9 years

Epistaxis

Excision

No recurrence

2 years

Pain maxillary
premolar
Pain, headaches,
seizures, hyposmia,
nasal obstruction
Nasal obstruction,
epistaxis
Nasal obstruction,
rhinorrhea, facial
swelling
Nasal obstruction

Excision, steroids

No recurrence

14 months

Excision

No recurrence

6 months

Excision

Recurrence

4 years

Excision, steroids

Recurrence

4 months

Excision

No recurrence

2 months

Excision

1 year
N/A

Alawi et al. [7]

1

F

32

Mandible

Mandible swelling,
pain
Maxillary pain,
swelling

Excision

No recurrence

13 months

Keskin et al.
[34]

1

F

29

Dickson1
Gonzales et al.
[35]
Ilie et al. [36]
1

F

56

Maxillary 2nd
molar alveolar
ridge
Maxillary sinus

None, observation

Persistent
disease

16 months

Hard palate Swelling

Excision

N/A

N/A

F

43

Nasal cavity

Nasal obstruction,
epistaxis, pain
Nasal obstruction,
epistaxis, anosmia

Excision

Recurrence

3 years

Sellari1
Franceschini
et al. [37]
Demicco et al. 1
[38]
Ojha et al. [39] 1

F

26

Nasal septum

Excision, steroids

No recurrence

19 years

M

18

Maxilla

N/A

N/A

35 months

Maxillary 2nd
molar alveolar
ridge
Nasal cavity

Maxillary pain

Excision, radiation

Persistent
disease
No recurrence

F

47

Khan et al.
[40]

1

F

30

Excision,
cyclophosphamide,
vincristine, steroids,
iron
Excision

N/A

N/A

Tekin et al.
[41]

1

F

23

No recurrence

3 years

Zhu et al. [42]

3

M

27

Excision

Persistent
disease

2 years

M

28

Excision, steroids

Intracranial &
lung lesion,
metastases

16 months

Nasal obstruction,
orbital protrusion,
decreased vision,
rhinorrhea
Mandible
Pain, swelling
mandibular premolar
s/p extraction
Nasal cavity and Headache, nasal
paranasal
obstruction,
sinuses
rhinorrhea, epistaxis
Nasal cavity and Nasal obstruction,
paranasal
lacrimation, facial
sinuses
swelling

10 months

M

53

Nasal cavity and
paranasal
sinuses
Nasal cavity,
septum
Nasal cavity,
maxillary sinus

Nasal obstruction,
rhinorrhea, epistaxis

Excision, steroids

Recurrence

1 year

Nasal obstruction,
epistaxis
Nasal obstruction,
facial mass

Excision

No recurrence

6 weeks

Excision

25 months

Difficulty breathing

Excision

Persistent
disease with
regression
No recurrence

Lai et al. [43]

1

F

41

Zhao et al.
[44]

1

F

11

Akyigit et al.
[45]
Duan et al. [8]

1

M

15

Nasal septum

7

M

21

Nasal cavity,
paranasal
sinuses
Nasal cavity,
paranasal
sinuses
Nasal septum

6 months

Nasal obstruction,
Excision
Recurrence
5.5 years
facial asymmetry,
Hyposmia
M 31
Nasal obstruction,
Excision
Recurrence
51 months
aural fullness,
hyposmia
F
32
Nasal obstruction,
Excision
Multiple
5.33 years
dyspnea, epistaxis,
recurrences
hyposmia
F
44 Nasal septum
Epistaxis, nasal
Excision
Recurrence
39 months
dorsum lesion
F
53 Nasal septum
Epistaxis
Excision
No recurrence 6 months
F
53 Nasal septum
Nasal dorsum lesion
Excision
No recurrence 6.5 years
M 58 Nasal cavity,
Nasal obstruction,
Excision
No recurrence 10 years
paranasal
decreased vision,
sinuses
hyposmia
Hamza et al.
1
F
27 Mandible
Swelling, pain,
Excision
No recurrence N/A
[46]
loosening of teeth
Age range: 6–69 years (mean: 38 years); Gender distribution: Male: 15, Female: 23; Site distribution of cases: nasal cavity and nasal septum:
32 cases, maxillary sinus: 14 cases, jaw bones: 8 cases

Results
Clinical and Radiographic Findings

Six cases in our series affected women and one case was diagnosed in a male. The age range was from
22 years to 55 years with a mean of 38.14 years.
Case 1

This 46-year-old female presented with pain of approximately 6 months duration and a non-healing extraction
site from a maxillary molar. An axial CT showed an expansile osteolytic process of the right posterior maxilla
with buccal cortical plate and tuberosity resorption and extension into the right maxillary sinus (Fig. 1). A biopsy
of the posterior maxilla and maxillary sinus contents was done.

Fig. 1 Axial CT (Case 1) demonstrating an osteolytic process of the right maxilla
Case 2
A 26-year-old female presented with pain and mobility of the lower left first molar. The symptoms
were noted to be increasing gradually over 4–5 months. Radiographic examination showed multiple
irregular osteolytic foci of varying size. The superior alveolus showed a scooped-out outline. Tooth #19
appeared extruded and its roots showed reduced bone support. Tooth #18 was missing, having been
extracted 4–5 months before (Fig. 2). A biopsy of one of the osteolytic foci was obtained. A concurrent
upper arm mass was also biopsied.

Fig. 2 Panoramic radiograph (Case 2) demonstrating multiple osteolytic areas of left mandible. A scooped-out
appearance of the superior alveolus is seen

Case 3
Patient three had over a 15-year history of chronic sinusitis which was refractory to over the counter
nasal sprays and allergy medications. Nasal endoscopy showed a mass of the right nasal cavity
involving the inferior turbinate. ACT scan showed a 3.0 × 1.5 × 3.0 cm mass in the right anterior nasal
cavity involving the anterior and mid portions of the inferior and middle turbinates. No other masses or
lesions were identified radiographically or clinically. A biopsy was obtained with a diagnosis consistent

with RDD. Endoscopic excision of the right nasal cavity mass including partial right inferior
turbinectomy was performed.
Case 4
Patient four had symptoms of chronic sinusitis for over 10 years with bilateral membrane removal from
the maxillary and anterior ethmoid sinuses. Symptoms persisted and endoscopic antrostomy with
mucous membrane removal from the bilateral maxillary and ethmoid sinuses was again performed and
a diagnosis of ENRDD was given.
Case 5
Patient five had a complaint of nasal obstruction with bilateral nasal polyps. These polyps were excised
and diagnosed as ENRDD on the basis of histopathological and immunohistochemical findings.
Case 6
A 26-year-old male developed a radiolucent lesion of the right posterior mandible that extended from
the body to the mid ramus (Fig. 3 cropped panoramic X-ray). Cortical thinning with no significant bone
expansion was seen (Fig. 3 CT axial slice). The right mandibular third molar had been extracted 6–
7 years ago. A biopsy was performed in the area of the extraction site.

Fig. 3 Cropped panoramic radiograph and axial CT slice (Case 6) showing an osteolytic process of the right

posterior mandible extending to the mid ramus. The axial CT slice shows lesion (arrow) causing cortical thinning
but no significant expansion

Case 7
This 38-year-old female developed a rapidly growing mass in her right posterior mandible 3.5 months
following a tooth extraction. CT imaging showed a well-demarcated expansile mass with buccal and
lingual cortical plate compromise (Fig. 4).

Fig. 4 Clinical and CT images (case 7) show a mass of the right posterior mandible causing expansion with buccal
and lingual cortical plate compromise

Histopathological and Immunohistochemical Findings

Histopathological features were fairly consistent across the seven cases. Sheets of large cells with a
bright pink to slightly granular and occasionally foamy to vacuolated cytoplasm were seen. The cells
showed a relatively well-defined cell membrane. A single, prominent dark nucleus was seen (Fig. 5a).
Inflammation was consistently present and consisted of lymphocytes, plasma cells and neutrophils.
Eosinophils were seen in only case five (Fig. 5b). A mixed leukocytic phagocytosis was seen (Fig. 5c).
Macrophage markers including CD68 (Fig. 5d), CD163 and alpha-1-antitrypsin were variably used in
four cases (Cases 1, 2, 6 and 7) and were positive. Langerhans cell marker CD1a was used in only case
one and two and tested negative. The cells were positive to S100 protein in all cases and phagocytosed
lymphocytes (emperipolesis) remained unstained (Figs. 6, ,7b7b and d, arrows). Emperipolesis was
easier to detect in H & E stained sections in cases 6 and 7 (Fig. 7a and c respectively, arrows). The
histopathological features and the immunohistochemistry reactivity were consistent with a diagnosis
of Rosai-Dorfman disease in each of the cases.

Fig. 5 a Sheets of large histiocytic cells with a well-defined cytoplasmic membrane and light eosinophilic to

vacuolated cytoplasm and a single prominent nucleus are mixed with variably dense inflammation. (H & E, 20×).
b Inflammatory infiltrate comprised of lymphocytes, plasma cells and neutrophils. Eosinophils were seen in only
case five. (H & E, 20×). c A mixed leukocytic phagocytosis was seen in all cases. Lymphophagocytosis
(emperipolesis) was not prominent (H & E, 20×). d The cells expressed strong and diffuse reactivity to CD68
(20×)

Fig. 6 Emperipolesis is evident in S100 stained tissue (arrows) (20×)

Fig. 7 Lymphocytic emperipolesis (arrows) is seen in H & E stained sections in Case 6 (a, 40×) and Case
7 (c, 40×). These lymphocytes appear prominent within the S100 protein positive histiocytes (b, Case 6)
and (d, Case 7)

Management and Follow-Up

The mandibular lesion in case two was removed by aggressive curettage and the upper arm mass was
excised. The upper arm mass was diagnosed as RDD as well. The patient is disease free through a
follow-up period of 2 years. The lesion of the maxilla (case 1) is currently stable and under observation.
Cases 3, 4 and 5 are disease free at post-excision intervals of 2, 3 and 3 years respectively. Mandibular
lesions in Cases 6 and 7 were removed by aggressive curettage. The oral mass in Case 7 was excised
simultaneously. No follow-up information is available on Cases 6 and 7.

Discussion

Sinus histiocytosis with massive lymphadenopathy (SHML), also known as Rosai-Dorfman disease
(RDD), is a rare, non-neoplastic histiocytosis of unknown etiology, first described in 1969 [1]. It is
usually seen in the first two decades of life with about 62% of the cases occurring in patients under
10 years of age and 81% of cases occurring in patients under 20 years of age. The age range is however
from 1–69 years [6]. The age of patients in our series ranged from 22 years to 55 years with a mean of
41 years and a median of 46 years. RDD does not exhibit any predilection based on gender, race or
socioeconomic status [6]. However, all patients in our series were females. The most common clinical
manifestation of RDD is bilateral cervical lymphadenopathy. Constitutional symptoms such as fever,
malaise, weight loss and night sweats may also be present [7]. Approximately 43% of patients present
with extranodal lesions of RDD [3, 8].
However, RDD without nodal involvement is extremely rare. The most common extranodal locations
for RDD are the skin, nasal cavity, eyes and the bones [4]. Table 2 lists 38 cases of extranodal RosaiDorfman disease (ENRDD) of the head and neck. The age of patients ranged from 6–69 years with a
mean of 38 years. Females were affected more than males (23:15). The nasal cavity and paranasal
sinuses were by far the most common location followed by the jawbones. RDD of the nasal cavity and
paranasal sinuses present as a polyp causing variable degrees of obstruction, swelling, facial
asymmetry, nasal discharge, hyposmia, headache, epistaxis, lacrimation and proptosis. The five
patients in our series denied constitutional symptoms. The two nasal cavity lesions presented as
obstruction causing masses while the lesion spanning the nasal cavity and paranasal sinuses presented
symptoms of chronic sinusitis. The maxillary bone lesion was discovered in association with a painful

non-healing extraction socket. The mandibular bone lesion also presented with pain and tooth mobility
(Table 3).
Table 3 Differential diagnosis of histopathological mimics of Rosai-Dorfman disease of the head and
neck
Disease

Histopathological features

Rosai-Dorfman
disease

Sheets of large cells with bright
pink slightly granular to foamy
cytoplasm, single prominent
dark nucleus. Variable patchy
inflammation with polyclonal
plasma cells, reactive B and T
cells. Although leukocytic
phagocytosis is common,
emperipolesis of lymphocytes
is hard to discern
Large macrophages with a clear
to foamy cytoplasm (Mikulicz
cells) admixed with
lymphocytes and numerous
plasma cells. Squamous
metaplasia or
pseudoepitheliomatous
hyperplasia of surface
epithelium
Sheets of ovoid or epithelioid
cells with pale cytoplasm,
irregular nuclear grooves, folds
or indentations (kidney/coffee
bean nuclei). Prominent tissue
eosinophilia to eosinophilic
abscess formation. Other
inflammatory cells,
multinucleated cells, foamy
histiocytes may be variably
present
Loose to compact sheets of
large round to oval to rarely
plump spindled cells with a
granular to foamy cytoplasm
with vesiculated or intensely
dark nuclei. Unperforated
lesions may show little
inflammation. Occasional
multinucleated cells

Rhinoscleroma

Langerhans
cell
histiocytosis

Central
xanthoma

Immunohistochemical
features
Cells are CD68, CD163
and S100 positive (often
helps highlight
emperipolesis)
Cells are CD1a and CD207
(Langerin) negative

Ancillary findings

Macrophages are CD68
and CD163 positive
Macrophages are S100,
CD1a and CD207 negative

Warthin-Starry silver
stain shows bacteria
K. rhinoscleromatis
within macrophages

Cells are S100, CD1a and
CD207 positive
Cells are CD163 negative.
CD68 is variable

Electron microscopy:
Tennis racket shaped
Birbeck granules

Cells are CD68 and CD163
positive
Cells are S100 and CD207
negative

ErdheimChester
disease

Foamy histiocytes within
thickened bone trabeculae.
Occasional multinucleated
giant cells. Small clusters of
Langerhans cells may be
present

Cells are CD68 and CD163
positive
Small clusters of
Langerhans cells will be
S100 and CD1a positive
(These clusters are a
minor population relative
to the histiocytes)

BRAF V600E
mutations in up to
100% of patients
Note: A diagnosis is
made only upon
correlation with
clinical features
(upper and lower
limb lesions with
bone pain is most
common) and
identification of
above mutation

The clinical differential diagnosis of RDD of the paranasal sinuses includes rhinosinusitis, sinonasal
polyps, rhinoscleroma, and granulomatosis with polyangiitis (Wegener’s Granulomatosis).
Rhinosinusitis is a common condition caused by bacterial or viral infections or environmental allergens.
Symptoms include nasal stuffiness, sneezing, and drainage. Microscopic examination shows mucosal
edema with a mixed inflammatory infiltrate. A predominance of eosinophils in the infiltrate suggests
an allergic etiology [9]. Sinonasal polyps result from repeated rhinosinusitis. They usually occur in the
nasal cavity, maxillary or ethmoid sinuses, and present with rhinorrhea, stuffiness, obstruction, and
headache. Radiologically they present as multiple expansible masses within the nasal cavity or
paranasal sinuses. Histopathological examination shows edematous stroma with a lymphoplasmacytic
infiltrate, mucoserous glands with goblet cell hyperplasia or metaplasia, and myofibroblastic stromal
cells with reactive atypia [10]. Rhinoscleroma is a granulomatous bacterial infection caused by
Klebsiella rhinoscleromatis. It common in Egypt, south Asia, central & south America, north & central
Africa, and eastern Europe. In the US, lesions may be encountered in the immigrant population or in
recent visitors to endemic areas. Patients present with nasal discharge, obstruction, expansion and
deformity. Microscopic examination of infected tissue shows a granulomatous proliferation of
macrophages containing silver stain positive bacteria [11]. Granulomatosis with polyangitis (GPA) is a
small and medium vessel vasculitis. GPA affects the sinuses, lungs and kidneys most commonly, but
lesions of the eye, ears, skin, nerves, joints, oral cavity and other organs have also been recorded.
Nasal congestion, nosebleeds, shortness of breath, and bloody cough are early manifestations of GPA.
Joint pain, decreased hearing, skin rashes, eye redness and/or vision changes, fatigue, fever, appetite
and weight loss, night sweats, and numbness or loss of movement in the fingers, toes or limbs, oral
ulcers and a strawberry gingivitis are other presenting features of GPA. Patients with GPA demonstrate
elevated serum antineutrophil cytoplasmic antibodies (C-ANCA) [12, 13].
RDD of the jawbones presents with intermittent pain and bone loss. A slow expansion may also be
present. Radiographically, jawbone lesions of RDD may present as an ill-defined osteolytic process to
variably sized multiple foci of osteolysis. The clinical and radiographic differential diagnosis of jaw
lesions of RDD would include reactive, infectious and neoplastic processes such as Langerhans cell
histiocytosis (LCH), osteomyelitis, metastatic disease, carcinoma and lymphoma. Jaw lesions of LCH
present as punched-out lucencies. Larger lesions produce a scooped out bone loss affecting the

alveolus. These osteolytic foci are accompanied by pain, swelling and loosening of teeth [14].
Osteomyelitis of the jaws is usually due to uncontrolled dental infection. Pain, swelling,
lymphadenopathy and other constitutional signs and symptoms of an inflammatory process are seen.
Radiographically, osteomyelitis appears as a moth-eaten, mixed opaque/lucent lesion. Widening of the
periodontal ligament, loss of lamina dura, and periosteal new bone formation may also be seen [14].
Jawbone metastatic disease and lymphoma may present with persistent vague pain, discomfort and
tooth mobility. In advanced stages, patients may also experience numbness of lip and pathologic
fractures. The diagnosis rests on histopathological examination of biopsied tissue [14, 15].
Histopathological examination of RDD shows sheets of large cells with a pink cytoplasm and a
prominent nucleus characteristic of histiocytes. Inflammation is always present. Its distribution and
intensity is variable. Jaw lesions in association with loose teeth may show greater amounts of
inflammation that may obscure the diagnosis. RDD of the lymph nodes shows distended nodal sinuses
packed with histiocytes demonstrating emperipolesis of lymphocytes. Occasionally neutrophils and red
cells may also be phagocytosed. As encountered in our five cases, emperipolesis is harder to evaluate
in ENRDD and is best recognized following S100 protein immunohistochemistry, where the histiocytes
of RDD express strong cytoplasmic and nuclear reactivity to S100 protein. The lymphocytes within the
intracytoplasmic emperipolesis vacuoles remain unstained (Fig. 4). The histiocytes are CD68, CD163
and Alpha-1-antitrypsin positive [16].
Histopathologically, RDD resembles LCH, central xanthoma, rhinoscleroma and Erdheim-Chester
disease. LCH is a class I dendritic cell histiocytosis and it was reclassified as an “L” group of
histiocytosis. Clonal mutations involving genes of the MAPK pathway are detected in 80% of cases [17].
A recent study showed a subgroup of cases of RDD with mutually exclusive KRAS and MAP2K1
mutations (7 cases, N = 21) with 6 out of 7 (86%) cases expressing these point mutations being
localized to the head and neck [18]. The diagnosis of LCH is based on a combination of clinical and
radiographic findings in association with histopathological identification of mononuclear histiocytes
with a coffee bean or kidney shaped nucleus. In routine pathological diagnostic practice, detection of
Birbeck granules by electron microscopy has been replaced by immunohistochemical detection of
CD1a and CD207 (Langerin) in the histiocytes. Lesional tissue also shows abundant eosinophils and
multinucleated giant cells [17]. Rhinoscleroma and RDD can show some overlapping features including
presentation in the respiratory tract and lymph nodes and a prominent histiocytic infiltrate.
Rhinoscleroma will show a lymphoplasmacytic infiltrate with large, vacuolated macrophages known as
Mikulicz cells that harbor the bacteria made prominent with silver stains. Emperipolesis may also be
seen. Cases of concurrent rhinoscleroma and RDD have been reported. Histiocytes of rhinoscleroma
are S100 negative [19, 20]. Xanthoma of bone is a benign tumor consisting of a collection of granular to
foamy histiocytes arranged in loose or compact sheets of large, round to oval cells. These cells may
show cytoplasmic vacuolation and are CD 68 and CD 163 positive but S100 negative. [21]. ErdheimChester disease shows CD68 positive and S100 negative histiocytes with a granular cytoplasm. The
disease affects patients between ages of 40 and 60 years. Patients present with lower leg and upper
arm bone pain, headaches, seizures, cognitive impairment, diabetes insipidus, kidney and heart
disease. [22].

RDD that involves the jawbones and teeth may easily be misinterpreted as dental-related
inflammation.
RDD may demonstrate increased numbers of IgG4 + plasma cells. However, in the absence of fibrosis
with at least a focal storiform pattern, eosinophils in the inflammatory infiltrate and an obliterative
phlebitis, the possibility of IgG4-related disease can be excluded [23, 24].
ENRDD of the jaws and paranasal sinuses is an indolent, self-limiting disease. Some cases of ENRDD
have undergone spontaneous resolution. Observation and monitoring may be adequate in
asymptomatic patients. Masses of the nasal and paranasal sinuses producing symptoms of obstruction
are treated by conservative excision. Radiation therapy has also been used with some success, but this
is generally restricted to patients with vital organ involvement [8].

Conclusion

RDD or SHML is a relatively rare histiocytosis of unknown origin. A diagnosis of RDD is rarely suspected
in the absence of nodal involvement. Primary jaw, nasal and paranasal lesions , ENRDD are clinically
mistaken for other pathologic processes with a resultant delay in diagnosis and management.
Histopathologically, ENRDD of the head and neck shows relatively more mixed inflammation.
Lymphophagocytosis (emperipolesis) is not visualized as readily as in nodal disease. Due to these
features, ENRDD of the head and neck resembles a broad range of histiocyte rich common
inflammatory conditions and other neoplastic processes that need to be excluded to arrive at a correct
diagnosis.
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